Log in to your Inderes Free account to see all free content on this page.
Stayble Therapeutics
0.17 SEK
-3.93 %
Less than 1K followers
STABL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Stayble Therapeutics
P/B
Median 2020-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | - | 7.65 | 6.15 | 3.89 | 0.30 | 0.51 | 0.23 |
| Shares | 8.9 | 8.9 | 14.2 | 14.2 | 31.7 | 43.7 | 64.4 |
| Market cap | - | 68.2 | 87.5 | 55.4 | 9.6 | 22.3 | 14.5 |
| Enterprise value | - | 57.5 | 50.0 | - | - | - | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | - | neg. | neg. | - | - | - | - |
| EV/EBIT | - | neg. | neg. | - | - | - | - |
| P/E | - | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | - | 4.39 | 2.20 | 3.62 | 0.58 | 3.25 | 2.09 |
| P/S | - | - | - | - | - | - | - |
| Dividend yield | - | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | -3.0 % | 86.4 % | 91.2 % | 79.8 % | 76.1 % | 74.2 % | 80.3 % |
| Gearing ratio | - | 1.1 % | - | - | - | - | 12.3 % |
Login required
This content is only available for logged in users